Mathiesen T, Brattström C, Andersson J, Linde A, Ljungman P, Wahren B
Department of Virology, National Bacteriological Laboratory, Karolinska Hospital, Stockholm, Sweden.
J Med Virol. 1992 Jan;36(1):65-9. doi: 10.1002/jmv.1890360113.
The early activation of T- and B-cell responses to cytomegalovirus was studied in immunosuppressed patients. Primary lymphocyte stimulation to cytomegalovirus (CMV) antigen, a measure of T-helper activity, and anti-CMV IgG subclass responses were analyzed. Ten patients suffering from primary CMV infection following renal transplantation were studied. Of the ten, nine became positive for CMV induced lymphocyte proliferation 5-40 weeks after transplantation. Nine showed an almost simultaneous appearance of anti-CMV IgG1 and three at 3-32 weeks after transplantation, while one patient synthesized only low levels of anti-CMV IgG1. The lymphocyte proliferation assays have limited diagnostic value for primary CMV infection in renal transplant patients. The humoral and cellular immune responses seemed to be independent of each other.
对免疫抑制患者中巨细胞病毒(CMV)的T细胞和B细胞反应的早期激活进行了研究。分析了对CMV抗原的原发性淋巴细胞刺激(一种T辅助活性的指标)以及抗CMV IgG亚类反应。对10例肾移植后发生原发性CMV感染的患者进行了研究。在这10例患者中,9例在移植后5 - 40周CMV诱导的淋巴细胞增殖呈阳性。9例患者在移植后3 - 32周几乎同时出现抗CMV IgG1,3例患者在移植后3 - 32周出现抗CMV IgG1,而1例患者仅合成低水平的抗CMV IgG1。淋巴细胞增殖试验对肾移植患者原发性CMV感染的诊断价值有限。体液免疫和细胞免疫反应似乎相互独立。